Medipal Holdings Corp. revenue for the last year amounted to 25.29 B USD, the most of which — 16.43 B USD — came from its highest performing source at the moment, Prescription Drug Wholesale, the year earlier bringing 17.86 B USD. The greatest contribution to the revenue figure was made by Japan — last year it brought Medipal Holdings Corp. 25.29 B USD, and the year before that — 27.03 B USD.